Nepafin 0.1% Ophthalmic Suspension is a pain relieving medicine used to treat pain and inflammation associated with cataract surgery. It blocks and reduces the release of certain chemicals in the eye that cause pain and swelling. This makes the healing process after eye surgery more comfortable and helps the eye heal faster.

It is a non-steroidal anti-inflammatory drug (NSAID)

Uses of Nepafin Ophthalmic Suspension

Treatment of Post-operative eye pain and inflammation

Benefits of Nepafin Ophthalmic Suspension

In Treatment of Post-operative eye pain and inflammation

Nepafin 0.1% Ophthalmic Suspension helps relieve symptoms such as pain, redness, swelling, itching and watering of eyes after an operation of the eyes. This medicine works by decreasing the production of certain chemicals that cause inflammation of the eyes. This will make it easier for you to go about your daily activities. Use it as prescribed to get the most benefit. If you see no improvement even after a week, talk to your doctor.

Side effects of Nepafin Ophthalmic Suspension

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Nepafin

Decreased vision
Foreign body sensation in eyes
Increased intraocular pressure
Stickiness

How to use Nepafin Ophthalmic Suspension

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.

How Nepafin Ophthalmic Suspension works

Nepafin 0.1% Ophthalmic Suspension is a non-steroidal anti-inflammatory drugs (NSAID) which works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling) in the eye.

Safety advice

Alcohol

No interaction found/established

Pregnancy

CONSULT YOUR DOCTOR

Nepafin 0.1% Ophthalmic Suspension may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Information regarding the use of Nepafin 0.1% Ophthalmic Suspension during breastfeeding is not available. Please consult your doctor.

Driving

UNSAFE

Nepafin 0.1% Ophthalmic Suspension may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.

Kidney

No interaction found/established

Liver

No interaction found/established

What if you forget to take Nepafin Ophthalmic Suspension?

If you miss a dose of Nepafin 0.1% Ophthalmic Suspension, use it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Nepafin 0.1% Ophthalmic Suspension

₹55.5/Ophthalmic Suspension

Nepalact Eye Drop

Sun Pharmaceutical Industries Ltd

₹199.6/ophthalmic suspension

80% costlier

Nevanac Ophthalmic Suspension

Alcon Laboratories

₹320/ophthalmic suspension

188% costlier

Nepaflam Eye Drop

Ajanta Pharma Ltd

₹194/ophthalmic suspension

75% costlier

Eyedol Eye Drop

Akumentis Healthcare Ltd

₹145/ophthalmic suspension

31% costlier

Nepastar Eye Drop

Mankind Pharma Ltd

₹165/ophthalmic suspension

49% costlier

View all substitutes

Quick tips

Your doctor has prescribed Nepafin 0.1% Ophthalmic Suspension for the relief of post-operative eye pain and inflammation (redness and swelling).
Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the drop.
Usually, a 4 to 6-week course may be necessary.
Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
Stinging sensation may occur for 1-2 mins. Notify your doctor if it persists for longer.
Notify your doctor if you are on blood thinners or have bleeding problems.
Use the eye drops within 4 weeks of opening the bottle.

Fact Box

Chemical Class

Benzophenone Derivatives

Habit Forming

Therapeutic Class

OPHTHAL

Action Class

NSAID's- Non-Selective COX 1&2 Inhibitors (Topical)

Patient concerns

i have met an accident and as per x-ray left hand wrist joint is affected. pls check my reports attached. i have gone through surgery and plating is done. i want to know if plating and surgery was necessary or not.

Dr. Akshat Goel

Orthopaedics

Please share the pics of pre-operative and post-operative X-rays

post operative care after squint surgry

Dr. Richa Jain

Ophthalmology

Protect eyes from water dust, smoke. Visit your doctor regularlyNo restrictions for food

Top Ophthalmologists

Dr. Prem Vardhan

MBBS, MS, Fellowship, Fellowship

4.5 ★

Dr. Dheeraj Gupta

MBBS, MS, Fellowship

4.5 ★

Dr. Parul Sharma

MBBS, MS, DNB, Fellowship

4.2 ★

4.2 ★

4.5 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 970.
Nepafenac. Fort Worth, Texas: ALCON LABORATORIES, INC.; 2005 [revised Dec. 2012]. [Accessed 02 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). Nepafenac. [Accessed 02 Apr. 2019] (online) Available from:
Nepafenac [Product Information]. Mumbai, India: Lavue Pharmaceuticals Pvt. Ltd. [Accessed 25 Jul. 2023] (online) Available from:

Marketer details

Name: Finex Healthcare Pvt Ltd

Address: BUS STAND ROAD MALERKOTLA PB 148023 IN , - , .

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.